Rahika 150mg Tablet: Effective Relief for Your Health Needs

Uses:

• Treatment of non-small cell lung cancer (NSCLC) in adults with a mutation in the MET gene.

Active ingredient:

• Capmatinib.

Therapeutic effects:

• Rahika 150mg tablet is a kinase inhibitor that targets mesenchymal-epithelial transition (MET).
• It works by blocking the action of an abnormal protein that signals cancer cells to multiply, helping to slow or stop the spread of cancer cells.

Dosage and administration:

• It is an orally available prescription drug.
• The dose and duration are decided by the doctor based on the disease condition and other factors.
• Take the tablet with or without food.
• Do not break, chew, crush, or break the tablet. Swallow the whole tablet with water.

Safety advice:

• Do not take if allergic to Rahika 150mg tablet or any ingredients.
• Inform the physician if you have or have ever had lung or breathing problems other than your lung cancer, liver problems, or pancreatic problems.
• Avoid getting pregnant and breastfeeding during treatment. Use effective contraception to avoid pregnancy.
• Store at 20°C to 25°C.
• Protect the medicine from light and excessive moisture.
• Keep the medicine out of reach of children and pets.

Side effects:

• Common: swelling in the face and body, decrease in appetite, nausea, cough, fatigue.
• Serious: vomiting, liver injury, muscle pain, shortness of breath, lung infection, respiratory disease.

Interaction with other drugs:

• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, vaccinations, nutritional and vitamin supplements, and herbal products.

FAQs:

• Q1. What should I tell my healthcare provider before taking Rahika 150mg tablet?
  • Inform your physician about all your medical and medication history, including over-the-counter medicines and nutritional or vitamin supplements you are taking.
• Q2. How long do I have to take Rahika 150mg tablet?
  • The duration of your treatment depends on your disease condition and severity. Your doctor will decide your dose and duration of your treatment.
• Q3. Can Rahika 150mg tablet be given to kidney failure patients?
  • Yes, Rahika 150mg tablet is safe when prescribed to patients with kidney diseases. No dose adjustments are necessary. Inform your physician if you have any kidney diseases before initiating the treatment.
• Q4. Is Rahika 150mg tablet targeted therapy?
  • Yes, Rahika 150mg tablet is a targeted therapy. They work by targeting a mutation in MET gene. This helps slow or stop the spread of cancer cells.
• Q5. What if I overdose on Rahika 150mg tablet?
  • If you overdose on the medicine unintentionally or accidentally, seek medical advice immediately. Do not overdose on the medicine.

Fact box:

• Molecule name: Capmatinib.
• Therapeutic class: Anti-cancer.
• Pharmacological class: Protein Kinase Inhibitors.
• Indications: Non-small cell lung cancer (NSCLC).

Tags: Rahika, tablet, medication, 150mg, health, pharmacy, drug, medical, treatment